Results 101 to 110 of about 14,322 (328)

European experience on the practical use of levosimendan in patients with acute heart failure syndromes [PDF]

open access: yes, 2005
The novel calcium sensitizer and ATP-dependent potassium channel opener levosimendan has been introduced for routine use in several European countries. Recent reports on clinical experience confirm the positive hemodynamic results and beneficial clinical
Cardoso, JS, Follath, F, Franco, F
core   +1 more source

Myocardial Viability: What We Knew and What Is New

open access: yesCardiology Research and Practice, 2012
Some patients with chronic ischemic left ventricular dysfunction have shown significant improvements of contractility with favorable long-term prognosis after revascularization.
Adel Shabana, Ayman El-Menyar
doaj   +1 more source

Glucagon-Like Peptide-1

open access: yesJACC: Basic to Translational Science, 2016
Glucagon-like peptide-1-(7-36) amide (GLP-1) is a human incretin hormone responsible for the release of insulin in response to food. Pre-clinical and human physiological studies have demonstrated cardioprotection from ischemia-reperfusion injury.
Joel P. Giblett, BM, BSc   +3 more
doaj   +1 more source

Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1427-1436, April 2025.
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher   +12 more
wiley   +1 more source

Doppler tissue imaging in ST-elevation myocardial infarction [PDF]

open access: yes, 2011
Highly available, noninvasive and cost-effective, echocardiography remains a keystone in the evaluation of patients with coronary artery disease (CAD).
Witt, Nils
core   +2 more sources

Trimetazidine in coronary heart disease patients: mechanism of action and controlled trials’ results

open access: yesКардиоваскулярная терапия и профилактика, 2005
Metabolic cardioprotection is an important part of treating patients with coronary heart disease (CHD). The most widely used drug in this group is trimetazidine.
L. V. Kremneva   +2 more
doaj  

Takotsubo Cardiomyopathy Mimicking Stent Thrombosis After Percutaneous Coronary Intervention

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2018
Takotsubo cardiomyopathy, also known as “broken heart syndrome,” is a transient left ventricular dysfunction associated with stress (usually emotional) induced myocardial injury and stunning.
Furqan Khattak MD   +3 more
doaj   +1 more source

Anesthesia Management for a Patient Undergoing Pulmonary Endarterctomy without Cardiopulmonary Bypass [PDF]

open access: yesBrazilian Journal of Cardiovascular Surgery
Pulmonary endarterectomy is a curative procedure for chronic thromboembolic Pulmonary Hypertension. As usual, cardiopulmonary bypass circuit is required. However, there are several complications attributed to extracorporeal circulation.
Ayten Saracoglu   +5 more
doaj   +2 more sources

Microaxial pump‐supported coronary surgery without CPB to optimize outcome in severely impaired left ventricles

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Cardiopulmonary bypass (CPB) is the standard approach for coronary artery bypass grafting (CABG) in advanced ischaemic cardiomyopathy. Microaxial pump support has been envisioned to allow for beating‐heart CABG without CPB (MPCAB), thereby avoiding CPB‐inherent complications.
Anna Kathrin Assmann   +5 more
wiley   +1 more source

Myocardial Viability: From Proof of Concept to Clinical Practice

open access: yesCardiology Research and Practice, 2016
Ischaemic left ventricular (LV) dysfunction can arise from myocardial stunning, hibernation, or necrosis. Imaging modalities have become front-line methods in the assessment of viable myocardial tissue, with the aim to stratify patients into optimal ...
Aditya Bhat   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy